From our list 18 new health tech startups in Europe worth knowing (2026)
Vitroscope is a biotech company that develops perfusion platforms to study immune activity, treatment responses and disease mechanisms in living human tissue in real time; its benchtop platform vitro.alive keeps flow, oxygen, pH and temperature under control. Founded in 2019 by Carlo Kriesi (CEO) and Heikki Sjöman, it announced 7 million dollars on 3 November 2026: a 5 million dollar seed round co-led by Cerberus Ventures and YZR Capital, with Arcas Ventures, Golden Egg Check and Devico Invest, plus 2 million dollars in non-dilutive funding from the Research Council of Norway. Website: vitroscope.com. Sources: Tech.eu, The Hub.
Questions about Vitroscope
What does Vitroscope do?
Vitroscope: drug discovery data from living human tissue.
Where is Vitroscope based?
Vitroscope is based in Trondheim, Norway.
Where can I read more about Vitroscope?
Vitroscope is in our list 18 new health tech startups in Europe worth knowing (2026): https://meetnewbrands.com/articles/new-health-tech-startups-in-europe-2026